Others

Medicamen Biotech Ltd. - Outcome of Board Meeting

| Updated on November 13, 2018 Published on November 13, 2018

We wish to inform you that pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company at their meeting held today on 13 November 2018, inter alia, have considered and approved the following:

1. Un-Audited Financial Results for the quarter and half year ended 30 September 2018.

2. Limited Review Report provided by Statutory Auditors on the Un-Audited Financial Results for the quarter and half year ended 30 September 2018 of the Company.

The Board meeting commenced at 11.00 a.m. and concluded at 12.30 p.m.

Kindly acknowledge receipt of the same.

Pdf Link: Medicamen Biotech Ltd. - Outcome of Board Meeting

Source : BSE - www.bseindia.com

Published on November 13, 2018
This article is closed for comments.
Please Email the Editor